• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B型利钠肽水平可预测左心室辅助装置植入术后室性心律失常

B-Type Natriuretic Peptide Levels Predict Ventricular Arrhythmia Post Left Ventricular Assist Device Implantation.

作者信息

Hellman Yaron, Malik Adnan S, Lin Hongbo, Shen Changyu, Wang I-Wen, Wozniak Thomas C, Hashmi Zubair A, Pickrell Jeanette, Jani Milena, Caccamo Marco A, Gradus-Pizlo Irmina, Hadi Azam

机构信息

Krannert Institute of Cardiology, IU School of Medicine, Indianapolis, IN, USA.

Department of Biostatistics, IU School of Medicine, Indianapolis, IN, USA.

出版信息

Artif Organs. 2015 Dec;39(12):1051-5. doi: 10.1111/aor.12486. Epub 2015 Apr 10.

DOI:10.1111/aor.12486
PMID:25864448
Abstract

B-type natriuretic peptide (BNP) levels have been shown to predict ventricular arrhythmia (VA) and sudden death in patients with heart failure. We sought to determine whether BNP levels before left ventricular assist device (LVAD) implantation can predict VA post LVAD implantation in advanced heart failure patients. We conducted a retrospective study consisting of patients who underwent LVAD implantation in our institution during the period of May 2009-March 2013. The study was limited to patients receiving a HeartMate II or HeartWare LVAD. Acute myocardial infarction patients were excluded. We compared between the patients who developed VA within 15 days post LVAD implantation to the patients without VA. A total of 85 patients underwent LVAD implantation during the study period. Eleven patients were excluded (five acute MI, four without BNP measurements, and two discharged earlier than 13 days post LVAD implantation). The incidence of VA was 31%, with 91% ventricular tachycardia (VT) and 9% ventricular fibrillation. BNP remained the single most powerful predictor of VA even after adjustment for other borderline significant factors in a multivariate logistic regression model (P < 0.05). BNP levels are a strong predictor of VA post LVAD implantation, surpassing previously described risk factors such as age and VT in the past.

摘要

B型利钠肽(BNP)水平已被证明可预测心力衰竭患者的室性心律失常(VA)和猝死。我们试图确定在植入左心室辅助装置(LVAD)前的BNP水平是否能预测晚期心力衰竭患者LVAD植入术后的VA。我们进行了一项回顾性研究,研究对象为2009年5月至2013年3月期间在我们机构接受LVAD植入的患者。该研究仅限于接受HeartMate II或HeartWare LVAD的患者。急性心肌梗死患者被排除在外。我们比较了LVAD植入术后15天内发生VA的患者与未发生VA的患者。在研究期间,共有85例患者接受了LVAD植入。11例患者被排除(5例急性心肌梗死,4例未测量BNP,2例在LVAD植入术后13天前出院)。VA的发生率为31%,其中室性心动过速(VT)占91%,心室颤动占9%。在多变量逻辑回归模型中,即使在对其他临界显著因素进行调整后,BNP仍然是VA最有力的单一预测因子(P < 0.05)。BNP水平是LVAD植入术后VA的有力预测因子,超过了既往描述的诸如年龄和既往VT等危险因素。

相似文献

1
B-Type Natriuretic Peptide Levels Predict Ventricular Arrhythmia Post Left Ventricular Assist Device Implantation.B型利钠肽水平可预测左心室辅助装置植入术后室性心律失常
Artif Organs. 2015 Dec;39(12):1051-5. doi: 10.1111/aor.12486. Epub 2015 Apr 10.
2
Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients.植入式左心室辅助装置患者室性心律失常的死亡风险。
J Cardiovasc Electrophysiol. 2012 May;23(5):515-20. doi: 10.1111/j.1540-8167.2011.02223.x. Epub 2011 Nov 14.
3
B-type natriuretic peptide-guided therapy and length of hospital stay post left ventricular assist device implantation.B型利钠肽指导的治疗与左心室辅助装置植入术后住院时间
ASAIO J. 2015 Mar-Apr;61(2):156-60. doi: 10.1097/MAT.0000000000000182.
4
Effect of Ventricular Arrhythmia Ablation in Patients With Heart Mate II Left Ventricular Assist Devices: An Evaluation of Ablation Therapy.心室辅助装置HeartMate II患者室性心律失常消融的效果:消融治疗的评估
J Cardiovasc Electrophysiol. 2017 Jan;28(1):68-77. doi: 10.1111/jce.13114. Epub 2016 Nov 21.
5
Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices.持续血流左心室辅助装置患者室性心动过速消融的特点
Circ Arrhythm Electrophysiol. 2015 Jun;8(3):592-7. doi: 10.1161/CIRCEP.114.002394. Epub 2015 Apr 13.
6
Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT.脑利钠肽与轻度症状心力衰竭患者在 MADIT-CRT 中发生室性心动过速/心室颤动风险。
Heart Rhythm. 2016 Apr;13(4):852-9. doi: 10.1016/j.hrthm.2015.12.024. Epub 2015 Dec 25.
7
Association between biventricular pacing and incidence of ventricular arrhythmias in the early post-operative period after left ventricular assist device implantation.左心室辅助装置植入术后早期双心室起搏与室性心律失常发生率的关系。
J Cardiovasc Electrophysiol. 2022 May;33(5):1024-1031. doi: 10.1111/jce.15437. Epub 2022 Mar 19.
8
Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience.左心室辅助装置植入术后作为终点治疗的室性心动过速的特征:单中心消融经验。
JACC Clin Electrophysiol. 2017 Dec 11;3(12):1412-1424. doi: 10.1016/j.jacep.2017.05.012. Epub 2017 Aug 2.
9
Incidence, predictors, and clinical impact of electrical storm in patients with left ventricular assist devices: New insights from the ASSIST-ICD study.左心室辅助装置患者电风暴的发生率、预测因素和临床影响:来自 ASSIST-ICD 研究的新见解。
Heart Rhythm. 2019 Oct;16(10):1506-1512. doi: 10.1016/j.hrthm.2019.06.021. Epub 2019 Jun 27.
10
Ventricular arrhythmias following continuous-flow left ventricular assist device implantation: A systematic review.连续血流左心室辅助装置植入术后的室性心律失常:系统评价。
Artif Organs. 2020 Aug;44(8):E313-E325. doi: 10.1111/aor.13665. Epub 2020 Mar 8.

引用本文的文献

1
A Review of New-Onset Ventricular Arrhythmia after Left Ventricular Assist Device Implantation.左心室辅助装置植入后新发室性心律失常的研究综述。
Cardiology. 2022;147(3):315-327. doi: 10.1159/000524779. Epub 2022 Apr 28.
2
Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence.左心室辅助装置患者的生物标志物:当前证据的洞察。
Biomolecules. 2022 Feb 19;12(2):334. doi: 10.3390/biom12020334.
3
Implantation of ventricular assist devices in hypertrophic cardiomyopathy with left ventricular systolic dysfunction.
肥厚型心肌病伴左心室收缩功能障碍患者的心室辅助装置植入术。
ESC Heart Fail. 2021 Dec;8(6):5513-5522. doi: 10.1002/ehf2.13653. Epub 2021 Oct 27.
4
Prognostic Value of Natriuretic Peptides for All-Cause Mortality, Right Ventricular Failure, Major Adverse Events, and Myocardial Recovery in Advanced Heart Failure Patients Receiving a Left Ventricular Assist Device: A Systematic Review.利钠肽对接受左心室辅助装置的晚期心力衰竭患者全因死亡率、右心室衰竭、主要不良事件及心肌恢复的预后价值:一项系统评价
Front Cardiovasc Med. 2021 Jul 7;8:699492. doi: 10.3389/fcvm.2021.699492. eCollection 2021.
5
Ablation therapy for ventricular arrhythmias in patients with LVAD: Multiple faces of an electrophysiological challenge.左心室辅助装置患者室性心律失常的消融治疗:电生理挑战的多面性
J Arrhythm. 2021 May 5;37(3):535-543. doi: 10.1002/joa3.12542. eCollection 2021 Jun.
6
Current Review of Implantable Cardioverter Defibrillator Use in Patients With Left Ventricular Assist Device.左心室辅助装置患者植入式心脏复律除颤器使用的当前综述
Curr Heart Fail Rep. 2019 Dec;16(6):229-239. doi: 10.1007/s11897-019-00449-8.
7
Cardiac Biomarkers in Advanced Heart Failure: How Can They Impact Our Pre-transplant or Pre-LVAD Decision-making.晚期心力衰竭中的心脏生物标志物:它们如何影响我们的移植前或左心室辅助装置植入前决策。
Curr Heart Fail Rep. 2019 Dec;16(6):274-284. doi: 10.1007/s11897-019-00447-w.